•
Mar 31, 2017

Outlook Therapeutics Q2 2017 Earnings Report

Total Revenue
$303K
Previous year: $995K
-69.5%
EPS
-$23.2
Previous year: -$32.8
-29.3%
Gross Profit
$0
0
Cash and Equivalents
$81K
Previous year: $2.84M
-97.1%
Total Assets
$17.5M
Previous year: $24.8M
-29.7%

Outlook Therapeutics

Outlook Therapeutics